Inhibiting GLUT1-dependent glycolysis limits the activation of macrophage AIM2 (Absent in Melanoma 2) inflammasomes, and specifically eliminating GLUT1 in bone marrow cells improves exacerbated fibrosis due to Streptococcus pneumoniae infection. This evidence concerns the gene SLC2A1 and pneumococcal infection.